References
- Boutwell AE, Nijhawan A, Zaller N, Rich JD. Arrested on heroin: a national opportunity. J Opioid Manage 2007;3(6):328–332.
- Winkelman TNA, Chang VW, Binswanger IA. Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use. JAMA Netw Open. 2018;1(3):e180558.
- Lopez G. How America’s prisons are fueling the opioid epidemic. Vox Media. https://www.vox.com/policy-and-politics/2018/3/13/17020002/prison-opioid-epidemic-medications-addiction. Published 2018. Accessed September 22, 2019.
- WHO Model List of Essential Medicines. https://www.who.int/medicines/publications/essentialmedicinesEML_2015_FINAL_amended_NOV2015.pdf. Published 2015. Accessed September 22, 2019.
- Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. World Health Organization https://www.who.int/substance_abuse/publications/opioid_dependence_guidelines.pdf. Published 2009. Accessed September 22, 2019.
- Substance Abuse and Mental Health Services Administration. Medications for Opioid Use Disorder. Treatment Improvement Protocol (TIP) Series 63, Full Document. HHS Publication No. (SMA) 19-5063FULLDOC. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2018.
- Moore KE, Roberts W, Reid HH, Smith KMZ, Oberleitner LMS, McKee SA. Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review. J Subst Abuse Treat. 2019;99:32–43.
- Hedrich D, Alves P, Farrell M, Stöver H, Møller L, Mayet S. The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction. 2012;107(3):501–517.
- Vestal C. New Momentum for Addiction Treatment Behind Bars. The Pew Chartiable Trusts. https://www.pewtrusts.org/en/research-and-analysis/blogs/stateline/2018/04/04/new-momentum-for-addiction-treatment-behind-bars. Published 2018. Accessed May 19, 2019.
- Linden M, Marullo S, Bone C, Barry DT, Bell K. Prisoners as patients: the opioid epidemic, medication-assisted treatment, and the eighth amendment. J Law Med Ethics. 2018;46(2):252–267.
- Backus L. Funding to help CT prisons improve opioid addiction treatment program. The Middletown Press. https://www.middletownpress.com/middletown/article/Funding-to-help-CT-prisons-improve-opioid-14069347.php. Published 2019. Accessed September 19, 2019.
- Faher M. More than 500 Vermon inmates recieving addiction treatment VTDigger. https://vtdigger.org/2019/01/23/500-vermont-inmates-receiving-addiction-treatment/. Published 2019. Accessed September 19, 2019.
- Vestal C. At Rikers Island, a Legacy of Medication-Assisted Opioid Treatment. The Pew Charitable Trusts. https://www.pewtrusts.org/en/researchandanalysis/blogs/stateline/2016/05/23/at-rikers-island-a-legacy-of-medicationassisted-opioid-treatment. Published 2016. Accessed September 19, 2019.
- Jones L. New York State Must Take Action to Reduce Opioid Overuse Deaths. Vera Institute of Justice. Think Justic Blog Web site. https://www.vera.org/blog/new-york-statemust-take-action-to-reduce-opioid-overuse-deaths. Published 2019. Accessed September 19, 2019.
- Governor Baker Signs Second Major Piece of Legislation to Address Opioid Epidemic in Massachusetts. Commonwealth of Massachusets. https://www.mass.gov/news/governor-baker-signs-second-major-piece-of-legislation-to-address-opioid-epidemic-in. Published 2018. Accessed October 6, 2019.
- Governor Murphy Announces New Initiatives to Combat the Opioid Epidemic. State of New Jersey. https://www.nj.gov/governor/news/news/562019/approved/20190123b.shtml. Published 2019. Accessed October 6, 2019.
- Friederich R. Corrections Takes Steps to Help Curb State’s Opioid Epidemic. Washington State Department of Corrections. https://www.doc.wa.gov/news/2018/11132018.htm. Published 2018. Accessed May 19, 2019.
- Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend. 2009;105(1–2):83–88.
- McKenzie M, Nunn A, Zaller ND, Bazazi AR, Rich JD. Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice. J Opioid Manage 2009;5(4):219–227.
- Public Policy Statement: Definition of Addiction American Soceity of Addiction Medicine. https://www.asam.org/docs/default-source/public-policystatements/1definition_of_addiction_long_4-11.pdf?sfvrsn=a8f64512_4. Published 2011. Accessed September 21, 2019.
- Leshner AI, Dzau VJ. Medication-based treatment to address opioid use disorder. JAMA 2019;321(21):2071–2072.
- Wakeman SE, Rich JD. Barriers to medications for addiction treatment: how stigma kills. Subst Use Misuse. 2018;53(2):330–333.
- McMillan GP, Lapham SC. Staff perspectives on methadone maintenance therapy (MMT) in a large southwestern jail. Addict Res Theor. 2005;13(1):53–63.
- Link BG, Phelan JC. Conceptualizing stigma. Annu Rev Sociol. 2001;27(1):363–385.
- Krieger N. Embodying inequality: a review of concepts, measures, and methods for studying health consequences of discrimination. Int J Health Serv. 1999;29(2):295–352.
- Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 2007;88(2–3):188–196.
- Olsen Y, Sharfstein JM. Confronting the stigma of opioid use disorder–and its treatment. JAMA 2014;311(14):1393–1394.
- Friedmann PD, Hoskinson R, Gordon M. Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Subst Abuse 2012;33(1):9–18.
- Matusow H, Dickman SL, Rich JD, et al. Medication assisted treatment in US drug courts: results from a nationwide survey of availability, barriers and attitudes. J Subst Abuse Treat. 2013;44(5):473–480.
- Rich JD, Boutwell AE, Shield DC, et al. Attitudes and practices regarding the use of methadone in US state and federal prisons. J Urban Health. 2005;82(3):411–419.
- White N, Ali R, Larance B, Zador D, Mattick RP, Degenhardt L. The extramedical use and diversion of opioid substitution medications and other medications in prison settings in Australia following the introduction of buprenorphine-naloxone film. Drug Alcohol Rev. 2016;35(1):76–82.
- Goodnough A, Zezima K. When Children’s Scribbles Hide a Prison Drug. The New York Times. https://www.nytimes.com/2011/05/27/us/27smuggle.html. Published 2011. Accessed September 27, 2019.
- Faul M, Bohm M, Alexander C. Methadone prescribing and overdose and the association with medicaid preferred drug list policies - United States, 2007–2014. MMWR Morb Mortal Wkly Rep. 2017;66(12):320–323.
- Lofwall MR, Walsh SL. A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world. J Addict Med. 2014;8(5):315–326.
- Coll S. The jail health-care crisis. Conde Nast. https://www.newyorker.com/magazine/2019/03/04/the-jail-health-care-crisis. Published 2019. Accessed 09/22, 2019.
- Henrichson C, Delaney R. The price of prisons: what incarceration costs taxpayers. Fed Sentencing Rep 2012;25:68.
- Caplan AL. Ethical issues surrounding forced, mandated, or coerced treatment. J Subst Abuse Treat. 2006;31(2):117–120.
- Cohen PJ. Untreated addiction imposes an ethical bar to recruiting addicts for non‐therapeutic studies of addictive drugs. J Law Med Ethics. 2002;30(1):73–81.
- Elliott C. Who holds the leash? Am J Bioeth. 2002;2(2):48–48.
- Charland LC. Cynthia's dilemma: consenting to heroin prescription. Am J Bioeth. 2002;2(2):37–47.
- Ludwig AS, Peters RH. Medication-assisted treatment for opioid use disorders in correctional settings: an ethics review. Int J Drug Pol. 2014;25(6):1041–1046.
- Moser DJ, Arndt S, Kanz JE, et al. Coercion and informed consent in research involving prisoners. Compr Psychiatry. 2004;45(1):1–9.
- Gostin LO. Biomedical research involving prisoners ethical values and legal regulation. JAMA 2007;297(7):737–740.
- Beauchamp TLC, James F. Principles of Biomedical Ethics. New York: Oxford University Press; 2009.
- U.S. Department of Health and Human Services (HHS), Office of the Surgeon General. Facing addiction in America: the surgeon general’s spotlight on opioids. https://addiction.surgeongeneral.gov/sites/default/files/Spotlight-on-Opioids_09192018.pdf. Published 2018. Accessed September 22, 2019.
- American Correctional Association and American Society of Addiction Medicine Release Joint Policy Statement on Opioid Use Disorder Treatment in the Justice System. American Correctional Association. https://www.aca.org/ACA_Prod_IMIS/DOCS/ACA-ASAM Press Release and Joint Policy Statement 3.20.18.pdf. Published 2019. Accessed September 23, 2019.
- Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2003;(2):CD002209.
- Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2004;(3):CD002207.
- Marsden J, Stillwell G, Jones H, et al. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addiction 2017;112(8):1408–1418.
- Niveau G. Relevance and limits of the principle of “equivalence of care” in prison medicine. J Med Ethics. 2007;33(10):610–613.
- Magura S, Lee JD, Hershberger J, et al. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. Drug Alcohol Depend. 2009;99(1–3):222–230.
- National Institute on Drug Abuse. Treating Opioid Addiction in Criminal Justice Settings National Institute on Drug Abuse. https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/policybrief-cj.pdf. Published 2017. Accessed September 21, 2019.
- Jones CM. Trends in methadone distribution for pain treatment, methadone diversion, and overdose deaths—United States, 2002–2014. MMWR Morb Mortal Wkly Rep. 2016;6526:667–671.
- Cicero TJ, Ellis MS, Chilcoat HD. Understanding the use of diverted buprenorphine. Drug Alcohol Depend. 2018;193:117–123.
- Pilkinton PD, Pilkinton JC. Prescribing in prison: minimizing psychotropic drug diversion in correctional practice. J Correct Health Care. 2014;20(2):95–104.
- Farahmand P, Modesto-Lowe V, Chaplin MM. Prescribing opioid replacement therapy in US correctional settings. J Am Acad Psychiatry Law 2017;45(4):472–477.
- Kuehn BM. Methadone overdose deaths rise with increased prescribing for pain. JAMA 2012;308(8):749–750.
- Modesto-Lowe V, Brooks D, Petry N. Methadone deaths: risk factors in pain and addicted populations. J Gen Intern Med. 2010;25(4):305–309.
- Estelle v. Gamble, 429 U.S. 97 (1976). Justia. https://supreme.justia.com/cases/federal/us/429/97/#tab-opinion-1952035. Accessed October 22, 2019.
- Rold WJ. Thirty years after Estelle v. Gamble: a legal retrospective. J Correct Health Care. 2008;14(1):11–20.
- Assembly UG. United Nations standard minimum rules for the treatment of prisoners (the Nelson Mandela Rules). UN GA Res 2015;70:175.
- Carter A, Hall W. Informed consent to opioid agonist maintenance treatment: recommended ethical guidelines. Int J Drug Pol. 2008;19(1):79–89.
- Jeste DV, Saks E. Decisional capacity in mental illness and substance use disorders: empirical database and policy implications. Behav Sci Law 2006;24(4):607–628.
- Bonnie RJ. Judicially mandated naltrexone use by criminal offenders: a legal analysis. J Subst Abuse Treat. 2006;31(2):121–127.
- Childress JF, Faden RR, Gaare RD, et al. Public health ethics: mapping the terrain. J Law Med Ethics. 2002;30(2):170–178.
- Hughes T, James Wilson D. Reentry Trends in the United States. Bureau of Justice Statistics. https://www.bjs.gov/content/reentry/reentry.cfm. Published 2019. Accessed September 27, 2019.
- Why does heroin use create special risk for contracting HIV/AIDS and hepatitis B and C? National Institute on Drug Abuse. https://www.drugabuse.gov/publications/research-reports/heroin/why-are-heroin-users-special-risk-contracting-hivaids-hepatitis-b-c. Published 2018. Accessed September 2, 2019.
- National Institute on Drug Abuse. Principles of drug abuse treatment for criminal justice populations – a research-based guide. National Institute of Drug Abuse. https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/txcriminaljustice_0.pdf. Published 2014. Accessed September 23, 2019.
- Larney S. Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review. Addiction. 2010;105(2):216–223.
- Murphy SM, Polsky D. Economic evaluations of opioid use disorder interventions. Pharmacoeconomics 2016;34(9):863–887.